Researchers at Israel’s Bar-Ilan University are working on Project HepaModulatoR with the University of Tübingen, Germany to correct damaged RNA causing chronic liver diseases. They have been awarded a multi-million Euro grant from the European Research Council.
Joint liver disease treatment with Germany
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.